Publication | Closed Access
Impact of Siponimod on Cognition in Patients With Secondary Progressive Multiple Sclerosis: Results From Phase 3 EXPAND Study (S44.004)
12
Citations
0
References
2018
Year
NeuropsychologyNeurological FunctioningCognitive PerformanceExpand StudyMedicineCognitive DysfunctionNeurological DisorderNeurological ProgressNeurological FunctionNeurologyNeuroscienceMultiple SclerosisNeurological DiseaseNeuroimmunologySocial SciencesPhase 3
To evaluate the effect of siponimod on cognition in secondary progressive multiple sclerosis (SPMS) patients.